Invitrogen Revenues and Earnings Up in Q2
Invitrogen’s revenues and earnings increased for the second quarter, the company reported this week.
Revenues increased approximately 32 percent to $254 million, compared to $192.4 million during the second quarter of 2003.
Invitrogen said the revenue growth included a 19 percent increase in its BioDiscovery unit, which is due principally to its Molecular Probes acquisition.
Research and development costs increased to $18.2 million, from $12.6 mllion during the same quarter last year.